Covid-19 Treatment

The first step in COVID-19 treatment is to determine if the resident has symptoms consistent with mild to moderate severity. Residents with COVID-19 with no hypoxia, and not requiring oxygen or no increased requirement from baseline, are mostly candidates for COVID-19 specific antiviral treatment because of the high risk conditions that increase the risk of progression to severe COVID-19.

Antiviral Medications

  Sample policies: Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir). Two oral antivirals, Paxlovid (nirmatrelvir with...

read more

Oxygen Therapy

The oral antivirals for COVID-19 are not for use in residents who have a new oxygen requirement for hypoxia or who have a higher oxygen...

read more


Dexamethasone is not recommended for treatment of residents with mild to moderate COVID-19 (patients not on supplemental oxygen for...

read more


Severe COVID-19 is associated with high D-dimer levels which appear to predict mortality. It is unknown whether antithrombotic treatments...

read more